CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...